| Application no. and date | 17849474.6 (espacenet) (Federated) (European Patent Register), 20170906 | | Patent/reg. no. and date | DK/EP 3512863, 20211208 | | Publication date | 20190724 | | Priority no. and date | US 201662384664 P, 20160907 | | EP pub. no. and date |
EP 3512863 20190724 | | Effective date | | | Applicant/owner | ATEA Pharmaceuticals, Inc., 125 Summer Street
Boston, MA 02110, US | | Applicant ref. no. | 6.2201.009 | | Inventor | SOMMADOSSI, Jean-Pierre, C/o Atea Pharmaceuticals, Inc. 125 Summer Street
Boston, MA 02110, US,
MOUSSA, Adel, C/o Atea Pharmaceuticals, Inc. 125 Summer Street
Boston, MA 02110, US | | Representative | Holme Patent A/S, Valbygårdsvej 33, 1, 2500 Valby, DK | | Opponent | | | IPC Class | A61K 31/675 (2006.01) , A61K 31/7076 (2006.01) , A61P 1/00 (2006.01) , A61P 31/14 (2006.01) , C07H 19/16 (2006.01) , C07H 19/20 (2006.01) , C07H 19/207 (2006.01) , C07H 23/00 (2006.01) | | Title | 2¿-substituerede-N6-substituerede purinnukleotider til behandling af RNA-virus | | Int. application no. | US2017050323 | | Int. publication no. | WO2018048937 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
